FDA Adverse Event Malfunction Summary report: N

ILET BIONIC PANCREAS

MDR report key: 24973780 · Received April 23, 2026

Report

Report Number
3019004087-2026-43769
Event Type
Malfunction
Date Received
April 23, 2026
Date of Event
March 28, 2026
Report Date
April 23, 2026
Manufacturer
BETA BIONICS INC.
Product Code
QFG
UDI-DI
00850050080190
PMA / PMN Number
K231485
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THE USER EXPERIENCED ELEVATED BLOOD GLUCOSE WHILE USING THE ILET, WITH FINGERSTICK VALUES IN THE 190¿275 MG/DL RANGE AND CGM VALUES IN THE 234¿255 MG/DL RANGE, THE CGM INITIALLY OUTSIDE EXPECTED ACCURACY, FOLLOWED BY SUCCESSFUL CALIBRATION AND A SUBSEQUENT INFUSION SITE CHANGE AFTER PERSISTENT HYPERGLYCEMIA DESPITE NO RECENT FOOD INTAKE AND NO OBSERVED TUBING ISSUES. SYMPTOMS INCLUDED HYPERGLYCEMIA. OUTCOMES INCLUDED NO HEALTH CONSEQUENCES OR IMPACT. INVESTIGATION INCLUDED TROUBLESHOOTING OF CGM CALIBRATION, TREND MONITORING, TUBING CHECKS FOR DROPS, AND AN INFUSION SITE CHANGE. INVESTIGATION OF THIS CASE REVEALED PERSISTENT ELEVATED GLUCOSE READINGS WITHOUT EVIDENCE OF LEAKAGE, KINKS, OR AIR IN THE TUBING, AND CALIBRATION OF THE CGM RESTORED EXPECTED SENSOR ALIGNMENT, SUGGESTING THE HYPERGLYCEMIA CAUSE WAS UNCLEAR. IT WAS CONCLUDED, BASED ON PREVIOUSLY ESTABLISHED FINDINGS FOR SIMILAR REPORTS, THAT THE CAUSE WAS UNCLEAR. IF THE DEVICE IS RETURNED, A PHYSICAL EVALUATION WILL BE PERFORMED, AND A SUPPLEMENTAL WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
83785 ILET BIONIC PANCREAS ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG BETA BIONICS INC. BB1001 00850050080190

Patients

Seq Age Sex Outcome Treatment
1 64 YR Unknown